CD39 as a Marker of Pathogenic CD8+ T Cells in Cancer and Other Chronic Inflammatory Diseases

Oncoscience - United States
doi 10.18632/oncoscience.404
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Impact Journals, LLC

Related search

CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+T Cells—Response

Cancer Research
Cancer ResearchOncology
2018English

MicroRNA in Human Cancer and Chronic Inflammatory Diseases

Frontiers in Bioscience - Scholar
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2010English

Regulatory T Cells and Inflammatory Bowel Diseases

Japanese Journal of Clinical Immunology
2004English

P53 Expression as a Prognostic Marker in Inflammatory Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

NADH Oxidase-Dependent CD39 Expression by CD8+ T Cells Modulates Interferon Gamma Responses via Generation of Adenosine

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2015English

Fetuin-A – Alpha2-Heremans-Schmid Glycoprotein: From Structure to a Novel Marker of Chronic Diseases Part 1. Fetuin-A as a Calcium Chaperone and Inflammatory Marker

Journal of Biomedical and Clinical Research
2017English

The Urinary Syndrome Under Acute and Chronic Purulent Inflammatory Diseases of Other Localization

UKRAINIAN JOURNAL OF SURGERY
2017English

CD39/CD73 and the Imbalance of Th17 Cells and Regulatory T Cells in Allergic Asthma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2013English

IL-35, a Hallmark of Immune-Regulation in Cancer Progression, Chronic Infections and Inflammatory Diseases

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy